TSHA Q1 2026 Earnings EPS Miss Highlights Ongoing DevelopmentStage Challenges AGIG Q3 2012 Earnings Significant EPS Miss Sends Stock Lower ASND Q1 2026 Earnings EPS Misses Estimates as Ascendis Pharma Navigates Cost Pressures DOX Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Lower NMRK Q1 2026 Earnings EPS Surpasses Estimates by 18 Stock Unchanged GEMI Q1 2026 Earnings Narrowed Loss Per Share Surprises to the Upside